VYCO Stock - Vycor Medical, Inc.
Unlock GoAI Insights for VYCO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.59M | $1.46M | $1.22M | $1.39M | $1.14M |
| Gross Profit | $1.42M | $1.32M | $1.08M | $1.26M | $1.01M |
| Gross Margin | 89.5% | 90.1% | 88.5% | 90.3% | 88.4% |
| Operating Income | $-9,145 | $40,191 | $-306,514 | $-435,954 | $-721,394 |
| Net Income | $-107,200 | $-69,691 | $-405,881 | $-523,473 | $-900,296 |
| Net Margin | -6.7% | -4.8% | -33.2% | -37.6% | -78.8% |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.02 | $-0.03 |
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.
Visit WebsiteEarnings History & Surprises
VYCOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $0.00 | — | — |
Q3 2025 | Aug 8, 2025 | — | $0.00 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.01 | — | — |
Q2 2025 | Apr 15, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 16, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 11, 2023 | — | $0.00 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.00 | — | — |
Q2 2023 | Apr 14, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 13, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 12, 2021 | — | $0.00 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 14, 2021 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about VYCO
What is VYCO's current stock price?
What is the analyst price target for VYCO?
What sector is Vycor Medical, Inc. in?
What is VYCO's market cap?
Does VYCO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VYCO for comparison